It is very difficult to estimate how many mergers and acquisitions in the pharmaceutical industry have succeeded. It is even more difficult to define what success means. K. Sreekanth Reddy, V. Balamuralidhara, Shilpi Khattri and T. M. Pramod Kumar of JSS College of Pharmacy, JSS University, Mysore look into the challenges of corporate takeovers, showing us why 80% of mergers do not meet their pre-merger financial goals and 50% become failures.
https://international-pharma.com/wp-content/uploads/2014/07/Merging.pdf
Current Edition
Current Edition
Subsection - CDMO
Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.
Continue readingSubsection - Injectables
Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.
Continue readingSubsection - Neurodegenerative Diseases
Exploring emerging approaches to neurodegenerative disease research and treatment.
Continue readingSubsection - Nasal & Pulmonary
Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.
Continue reading
Merging and Acquisition Perspective in Pharmaceutical Industry
